Eptinezumab
19140B
Phase 3 small_molecule completed
Quick answer
Eptinezumab for Migraine is a Phase 3 program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- H. Lundbeck A/S
- Indication
- Migraine
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed